XBiotech (XBIT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

Closed at $2.12, -1.85% vs the prior close of $2.16.
Volume 68.20K shares, 1.6x its 50-day average.
No new SEC filings since the prior session.
No new insider buys or sales reported since the prior session.

XBIT dips 1.9% to $2.12, a 6-month low, 5 down days in a row. Closed at $2.12, -1.85% vs the prior close of $2.16. Day range $2.10–$2.22, opened at $2.16.

Last close$2.12-1.85%

Day range2.10–2.22

Open2.16

Volume68.20K

52-week range2.09–3.44

Avg volume (20d)42.70K

XBIT daily analysis — what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 — XBIT dips 1.9% to $2.12, a 6-month low, 5 down days in a row

Closed at $2.12, -1.85% vs the prior close of $2.16. Day range $2.10–$2.22, opened at $2.16.
Volume was 68.20K shares, 1.6x its 50-day average of 43.33K.
Price is -4.8% vs its 50-day average ($2.23) and -9.9% vs its 200-day average ($2.35).
52-week range $2.09–$3.44; today's close sits at 2% of that range, 38.4% below the 52-week high.
That makes 5 straight losses.

Oct 15, 2026 — XBIT ends flat (+0.0%) to $2.16 on 2.0x normal volume

Closed at $2.16, +0.00% vs the prior close of $2.16. Day range $2.13–$2.26, opened at $2.16.
Volume was 85.00K shares, 2.0x its 50-day average of 42.34K — unusually heavy trading.
Price is -3.1% vs its 50-day average ($2.23) and -8.3% vs its 200-day average ($2.35).
52-week range $2.09–$3.44; today's close sits at 5% of that range, 37.2% below the 52-week high.
That makes 4 straight losses.

Oct 14, 2026 — XBIT ends flat (+0.0%) to $2.16, 3 down days in a row

Closed at $2.16, +0.00% vs the prior close of $2.16. Day range $2.15–$2.23, opened at $2.16.
Volume was 66.10K shares, 1.6x its 50-day average of 41.59K.
Price is -3.2% vs its 50-day average ($2.23) and -8.3% vs its 200-day average ($2.36).
52-week range $2.09–$3.44; today's close sits at 5% of that range, 37.2% below the 52-week high.
That makes 3 straight losses.

Oct 13, 2026 — XBIT slides 5.7% to $2.16 on 1.9x normal volume

Closed at $2.16, -5.68% vs the prior close of $2.29. Day range $2.15–$2.29, opened at $2.27.
Volume was 78.40K shares, 1.9x its 50-day average of 40.27K — unusually heavy trading.
Price is -3.3% vs its 50-day average ($2.23) and -8.4% vs its 200-day average ($2.36).
52-week range $2.09–$3.44; today's close sits at 5% of that range, 37.2% below the 52-week high.

Oct 12, 2026 — XBIT ends flat (+0.0%) to $2.29

Closed at $2.29, +0.00% vs the prior close of $2.29. Day range $2.25–$2.33, opened at $2.29.
Volume was 42.00K shares, 1.0x its 50-day average of 40.19K.
Price is +2.5% vs its 50-day average ($2.24) and -2.9% vs its 200-day average ($2.36).
52-week range $2.09–$3.44; today's close sits at 15% of that range, 33.4% below the 52-week high.

Oct 9, 2026 — XBIT jumps 4.1% to $2.29, a 1-month high on 2.3x normal volume

Closed at $2.29, +4.09% vs the prior close of $2.20. Day range $2.19–$2.29, opened at $2.21.
Volume was 88.00K shares, 2.3x its 50-day average of 38.57K — unusually heavy trading.
Price is +2.5% vs its 50-day average ($2.23) and -2.9% vs its 200-day average ($2.36).
52-week range $2.09–$3.44; today's close sits at 15% of that range, 33.4% below the 52-week high.
That makes 3 straight gains.

Oct 8, 2026 — XBIT rises 0.5% to $2.20

Closed at $2.20, +0.46% vs the prior close of $2.19. Day range $2.15–$2.22, opened at $2.19.
Volume was 13.00K shares, 0.3x its 50-day average of 39.02K — lighter than usual.
Price is -1.5% vs its 50-day average ($2.23) and -6.8% vs its 200-day average ($2.36).
52-week range $2.09–$3.44; today's close sits at 8% of that range, 36.0% below the 52-week high.

Oct 7, 2026 — XBIT rises 1.4% to $2.19 on 2.7x normal volume

Closed at $2.19, +1.39% vs the prior close of $2.16. Day range $2.16–$2.23, opened at $2.16.
Volume was 100.40K shares, 2.7x its 50-day average of 37.34K — unusually heavy trading.
Price is -2.0% vs its 50-day average ($2.23) and -7.3% vs its 200-day average ($2.36).
52-week range $2.09–$3.44; today's close sits at 7% of that range, 36.3% below the 52-week high.

Oct 6, 2026 — XBIT dips 0.9% to $2.16, 3 down days in a row

Closed at $2.16, -0.92% vs the prior close of $2.18. Day range $2.16–$2.19, opened at $2.18.
Volume was 11.70K shares, 0.3x its 50-day average of 37.71K — lighter than usual.
Price is -3.4% vs its 50-day average ($2.24) and -8.6% vs its 200-day average ($2.36).
52-week range $2.09–$3.44; today's close sits at 5% of that range, 37.2% below the 52-week high.
That makes 3 straight losses.

Oct 5, 2026 — XBIT dips 0.5% to $2.18

Closed at $2.18, -0.46% vs the prior close of $2.19. Day range $2.18–$2.20, opened at $2.20.
Volume was 32.70K shares, 0.9x its 50-day average of 37.50K.
Price is -2.6% vs its 50-day average ($2.24) and -7.8% vs its 200-day average ($2.36).
52-week range $2.09–$3.44; today's close sits at 7% of that range, 36.6% below the 52-week high.

Oct 2, 2026 — XBIT dips 0.5% to $2.19

Closed at $2.19, -0.45% vs the prior close of $2.20. Day range $2.19–$2.20, opened at $2.20.
Volume was 25.20K shares, 0.7x its 50-day average of 37.49K.
Price is -2.2% vs its 50-day average ($2.24) and -7.4% vs its 200-day average ($2.37).
52-week range $2.09–$3.44; today's close sits at 7% of that range, 36.3% below the 52-week high.
SEC filings that day: DEF 14A.

XBIT latest news & SEC filings

Every SEC filing by or about XBIT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 2, 2026 · Form ARS — Annual report to shareholders

Annual report to shareholders

Source: SEC EDGAR filing 0001171843-26-006363

Oct 2, 2026 · Form DEF 14A — Proxy statement

Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)

Source: SEC EDGAR filing 0001171843-26-006362

Aug 13, 2026 · Form 10-Q — Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Net income: -$6.73M (prior year -$1.76M) (loss widened vs Jun 30, 2025)
Diluted EPS: -$0.22 (prior year -$0.06) (loss widened vs Jun 30, 2025)

Source: SEC EDGAR filing 0001171843-26-005492

Things to know before you trade XBIT

Last results release: Jul 29, 2015 (8-K Item 2.02).
How much it moves: over the last 20 sessions the average daily move was 1.02% (largest 5.7%).
Liquidity: about 42.70K shares (≈$90.52K) trade per day on average. Thin volume can mean wider bid/ask spreads.
52-week position: $2.12 vs a range of $2.09–$3.44 (2% of the range).
Dividends: no cash dividends in the last 2 years.
Splits: none in the last 2 years.
Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
Latest filings: 10-Q Aug 13, 2026; 10-Q May 14, 2026; 10-K Mar 13, 2026.
Share count: 30.49M shares outstanding (Aug 13, 2026), +0.0% vs a year earlier.
Listing: Nasdaq · industry: Pharmaceutical Preparations.

XBIT market data (last 20 sessions)

Date	Open	High	Low	Close	Volume
Oct 16, 2026	2.16	2.22	2.10	2.12	68.20K
Oct 15, 2026	2.16	2.26	2.13	2.16	85.00K
Oct 14, 2026	2.16	2.23	2.15	2.16	66.10K
Oct 13, 2026	2.27	2.29	2.15	2.16	78.40K
Oct 12, 2026	2.29	2.33	2.25	2.29	42.00K
Oct 9, 2026	2.21	2.29	2.19	2.29	88.00K
Oct 8, 2026	2.19	2.22	2.15	2.20	13.00K
Oct 7, 2026	2.16	2.23	2.16	2.19	100.40K
Oct 6, 2026	2.18	2.19	2.16	2.16	11.70K
Oct 5, 2026	2.20	2.20	2.18	2.18	32.70K
Oct 2, 2026	2.20	2.20	2.19	2.19	25.20K
Oct 1, 2026	2.19	2.20	2.19	2.20	13.60K
Sep 30, 2026	2.18	2.21	2.18	2.19	62.80K
Sep 29, 2026	2.13	2.18	2.13	2.18	9.50K
Sep 28, 2026	2.16	2.19	2.15	2.15	41.70K
Sep 25, 2026	2.16	2.17	2.15	2.17	10.80K
Sep 24, 2026	2.17	2.19	2.16	2.16	24.00K
Sep 23, 2026	2.19	2.20	2.17	2.18	40.00K
Sep 22, 2026	2.21	2.21	2.18	2.18	9.10K
Sep 21, 2026	2.19	2.20	2.17	2.18	31.80K

About XBiotech

XBiotech (XBIT) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in AUSTIN, TX. State of incorporation: British Columbia, Canada. Fiscal year ends December 31. SEC CIK 1626878.

XBIT board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

Name	Role	Latest filing
Thomas Martin Kuendig	Director	Nov 12, 2025
Craig Evan Rademaker	Director	Nov 12, 2025
David Spencer Soffer	Director	Nov 12, 2025
Tevi David Troy	Director	Nov 12, 2025

Executive officers

Name	Title	Latest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

Date	Insider	Type	Shares	Price
No open-market insider buys or sales reported in the last 12 months.

XBIT financials (annual, from XBRL filings)

Fiscal year end	Revenue	Net income	Diluted EPS	Operating cash flow
Dec 31, 2025	—	$-45.54M	-1.49	$-39.92M
Dec 31, 2024	—	$-38.53M	-1.26	$-30.96M
Dec 31, 2023	—	$-24.56M	-0.81	$-18.73M
Dec 31, 2022	—	$-32.90M	-1.08	$-14.82M
Dec 31, 2021	—	$-17.41M	-0.58	$69.44M

Latest balance sheet: total assets $133.65M, total liabilities $5.19M, cash $109.53M (as of Jun 30, 2026).

XBIT earnings / results-day log

Date	Filing	Close that day
Jul 29, 2015	8-K Item 2.02 (results)	—

Related stocks · Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

More on XBIT

XBIT news & filings feed

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.